These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 29290021)
1. DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure. Qiu H; Wu H; Ma J; Cao H; Huang L; Qiu W; Peng Y; Ding C Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):323-334. PubMed ID: 29290021 [TBL] [Abstract][Full Text] [Related]
2. DL-3-n-butylphthalide improves ventricular function, and prevents ventricular remodeling and arrhythmias in post-MI rats. Qiu H; Ma J; Wu H; Ding C Naunyn Schmiedebergs Arch Pharmacol; 2018 Jun; 391(6):627-637. PubMed ID: 29602954 [TBL] [Abstract][Full Text] [Related]
3. Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits. Fu H; Li G; Liu C; Li J; Wang X; Cheng L; Liu T J Cardiovasc Electrophysiol; 2015 Feb; 26(2):211-22. PubMed ID: 25199622 [TBL] [Abstract][Full Text] [Related]
4. Dl-3-n-Butylphthalide improves lipopolysaccharide-induced depressive-like behavior in rats: involvement of Nrf2 and NF-κB pathways. Yang M; Dang R; Xu P; Guo Y; Han W; Liao D; Jiang P Psychopharmacology (Berl); 2018 Sep; 235(9):2573-2585. PubMed ID: 29943092 [TBL] [Abstract][Full Text] [Related]
5. Pinocembrin attenuates autonomic dysfunction and atrial fibrillation susceptibility via inhibition of the NF-κB/TNF-α pathway in a rat model of myocardial infarction. Ye T; Zhang C; Wu G; Wan W; Liang J; Liu X; Liu D; Yang B Int Immunopharmacol; 2019 Dec; 77():105926. PubMed ID: 31704291 [TBL] [Abstract][Full Text] [Related]
6. Danqi soft caspule prevents atrial fibrillation by ameliorating left atrial remodeling through inhibiting cardiac fibroblasts differentiation and function. Ma J; Ren M; Li J; Zheng C; Chen Q; Ma S Phytomedicine; 2022 Jul; 101():154134. PubMed ID: 35525237 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats. Zhang K; Ma Z; Wang W; Liu R; Zhang Y; Yuan M; Li G Cardiovasc Ther; 2018 Dec; 36(6):e12466. PubMed ID: 30203914 [TBL] [Abstract][Full Text] [Related]
8. Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications. Wang D; Sun L; Zhang G; Liu Y; Liang Z; Zhao J; Yin S; Su M; Zhang S; Wei Y; Liu H; Liang D; Li Y Cardiovasc Toxicol; 2021 Mar; 21(3):192-205. PubMed ID: 33099748 [TBL] [Abstract][Full Text] [Related]
9. Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model. Wu Q; Liu H; Liao J; Zhao N; Tse G; Han B; Chen L; Huang Z; Du Y Biomed Pharmacother; 2020 Sep; 129():110384. PubMed ID: 32554248 [TBL] [Abstract][Full Text] [Related]
10. Qiliqiangxin attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in rabbits. Tingting H; Guangzhong L; Yanxiang Z; DongDong Y; Li S; Li W Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):585-592. PubMed ID: 30627756 [TBL] [Abstract][Full Text] [Related]
11. CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post-Myocardial Infarction Rats. Liu M; Li W; Wang H; Yin L; Ye B; Tang Y; Huang C J Am Heart Assoc; 2019 Nov; 8(21):e013133. PubMed ID: 31623508 [TBL] [Abstract][Full Text] [Related]
12. Targeting Nrf2/HO-1 and NF-κB/TNF-α signaling pathways with empagliflozin protects against atrial fibrillation-induced acute kidney injury in rats. Badreldin H; El-Karef A; Ibrahim T; Elshal M Toxicology; 2024 Aug; 506():153879. PubMed ID: 38971551 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models. Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253 [TBL] [Abstract][Full Text] [Related]
14. Effects of butylphthalide on oxidative stress and inflammatory response in rats with myocardial infarction through Akt/Nrf2 signaling pathway. Bai M; Pan CL; Jiang GX; Zhang YM; Zhang Z Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9642-9650. PubMed ID: 31773715 [TBL] [Abstract][Full Text] [Related]
15. Intermedin 1-53 Ameliorates Atrial Fibrosis and Reduces Inducibility of Atrial Fibrillation via TGF-β1/pSmad3 and Nox4 Pathway in a Rat Model of Heart Failure. Ma S; Yan F; Hou Y J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836072 [TBL] [Abstract][Full Text] [Related]
16. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease. Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599 [TBL] [Abstract][Full Text] [Related]
17. Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model. Zhao Z; Chen Y; Li W; Wang X; Li J; Yang W; Cheng L; Liu T; Liu E; Li G Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):863-71. PubMed ID: 27118660 [TBL] [Abstract][Full Text] [Related]
18. Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits. Zhang X; Zhang Z; Zhao Y; Jiang N; Qiu J; Yang Y; Li J; Liang X; Wang X; Tse G; Li G; Liu T J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28507060 [TBL] [Abstract][Full Text] [Related]
19. Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53. Kataoka N; Nishida K; Kinoshita K; Sakamoto T; Nakatani Y; Tsujino Y; Mizumaki K; Inoue H; Kinugawa K Heart Vessels; 2016 Dec; 31(12):2053-2060. PubMed ID: 27236656 [TBL] [Abstract][Full Text] [Related]
20. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1. Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]